Versant Capital Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$132K Sell
371
-31
-8% -$10K 0.01% 802
2026
Q2
$194K Sell
402
-60
-13% -$15.9K 0.02% 630
2026
Q1
$50.6K Buy
462
+34
+8% +$4.84K 0.01% 1238
2025
Q4
$71.2K Buy
428
+50
+13% +$8.36K 0.01% 910
2025
Q3
$74K Hold
378
– – 0.01% 847
2025
Q2
$34.2K Sell
378
-29
-7% -$2.29K 0.01% 1202
2025
Q1
$24.3K Buy
+407
New +$37.6K ﹤0.01% 1240

Other funds holding ALAB

Versant Capital Management's ALAB Position: Q3 2026 in Review

Versant Capital Management reduced its Astera Labs (ALAB) stake by 7.7% in Q3 2026, selling an estimated $10K and leaving 371 shares worth $132K. The position accounts for 0.01% of the portfolio, ranked #802.

Versant Capital Management first reported a position in ALAB in Q1 2025 and has held it in 7 quarters since. The position peaked at $194K in Q2 2026. 310 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • Versant Capital Management held 371 shares of Astera Labs worth $132K as of Q3 2026.
  • Versant Capital Management sold 31 Astera Labs shares in Q3 2026, an estimated $10K.
  • Astera Labs made up 0.01% of Versant Capital Management's portfolio in Q3 2026, its #802 holding.
  • Versant Capital Management first reported a position in Astera Labs in Q1 2025 and has held it in 7 quarters since.
  • Versant Capital Management's Astera Labs position peaked at $194K in Q2 2026.
  • 310 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.